• Hemosiderin Stain, Urine
  • Blood Culture (Bloodstream Infection) Pathogen and Resistance Gene Panel, Molecular
  • Lyme Disease (Borrelia burgdorferi) Confirmatory Testing
  • Bone Marrow Aspiration
  • Human Papillomavirus (HPV), Low-Risk, DNA In Situ Hybridization
  • Macroprolactin, Serum
  • Culture, Leptospira
  • Infectious Mononucleosis Screen (Mono Test)
  • Rickettsia rickettsii DNA, Real-Time PCR
  • Hepatitis B Virus (HBV) by Molecular Method, Quantitative (Viral Load)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Methodology
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.